Artificial heart manufacturers Abiomed and SynCardia Systems on Monday announced that CMS has proposed to extend Medicare coverage to the devices for beneficiaries who participate in clinical trials approved by FDA, the More at...
Wednesday, February 6, 2008
Subscribe to:
Posts (Atom)
